University · founded 1962

Texas A&M University at Galveston

Galveston, United States · tamug.edu

Manage this page

Citations, last 5 years: 7 067
Works, last 5 years: 888
h-index: 177
Scientists listed: 91
Grants since 2016: 849

Grants received

2017–2021 · research · R25

Summer Research Experiences in Neurological Dysfunction

Giulio Taglialatela · Texas A&M University at Galveston · funded by National Institutes of Health

$105.4kHealth and Medical Research Impacts

2017–2020 · research · R21

Rational Development of a Novel Attenuated Rift Valley Fever Virus Vaccine

Shinji Makino · Texas A&M University at Galveston · funded by National Institutes of Health

$193.8kViral Infections and Vectors

2017–2024 · contract · N01

TASK A07: Rodent models for testing therapeutics against Filoviruses

David Beasley · Texas A&M University at Galveston · funded by National Institutes of Health

$577.8k

2017–2023 · cooperative agreement · U24

Academic Development of a Training Program for GLP in ABSL 3/4

Trevor Brasel · Texas A&M University at Galveston · funded by U.S. Food and Drug Administration

$360k

2017–2018 · research · R21

Notch signaling and functional relevance during Ehrlichia chaffeensis infection

Jere W Mcbride · Texas A&M University at Galveston · funded by National Institutes of Health

$229.2k

2017–2021 · research · R25

Summer Research Experiences in Neurological Dysfunction

Giulio Taglialatela · Texas A&M University at Galveston · funded by National Institutes of Health

$105.4kHealth and Medical Research Impacts

2017–2018 · fellowship · F31

Regulation of Cellular and Humoral Responses to Mouse Malaria

Victor Hugo Carpio Rojas · Texas A&M University at Galveston · funded by National Institutes of Health

$5 211Malaria Research and Control

2017–2024 · contract · N01

Task C11: Using a Human Lung Microphysiologic System to Model SARS-CoV-2 Infection and Test Candidate Countermeasures

David Beasley · Texas A&M University at Galveston · funded by National Institutes of Health

$431k

2017–2019 · research · R21

Impact of Neonatal Inflammation on Dysbiosis and Susceptibility to IBD

Qingjie Li · Texas A&M University at Galveston · funded by National Institutes of Health

$200.3k

2017–2021 · research · R01

(PQ9) A NOVEL MECHANISM OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY AND POTENTIAL TREATMENT

Qing Yang · Texas A&M University at Galveston · funded by National Institutes of Health

$356.4k

2017–2024 · contract · N01

Task A02: Murine models of Ascending UTI Infection caused by Drug-Resistant Bacteria

David Beasley · Texas A&M University at Galveston · funded by National Institutes of Health

$303k

2017–2020 · contract · N01

TASK A04: EVALUATION OF THERAPEUTICS AND VACCINES IN MOUSE MODELS OF DENGUE VIRUS

David Beasley · Texas A&M University at Galveston · funded by National Institutes of Health

$789.4k

2017–2022 · fellowship · F30

Advanced Glycation End-products, Exercise, and Sarcopenia

Amanda Randolph · Texas A&M University at Galveston · funded by National Institutes of Health

$42.7kAdvanced Glycation End Products research

2017–2021 · research · R01

Coupling activation of primary sensory neurons as a novel plasticity mechanism for chronic pain

Yu Shin Kim · Texas A&M University at Galveston · funded by National Institutes of Health

$368.1kPain Mechanisms and Treatments

2017–2022 · fellowship · F30

Advanced Glycation End-products, Exercise, and Sarcopenia

Amanda Randolph · Texas A&M University at Galveston · funded by National Institutes of Health

$35.5kAdvanced Glycation End Products research

2017–2022 · research · R01

Revolutionary Eilat-based Chikungunya Vaccine Vector

Tian Wang · Texas A&M University at Galveston · funded by National Institutes of Health

$855.8kMosquito-borne diseases and control

2017–2022 · research · R01

Pathogenic Role of EPAC1 Signaling in Retinopathy of Prematurity

Wenbo Zhang · Texas A&M University at Galveston · funded by National Institutes of Health

$387.5kRetinopathy of Prematurity Studies

2017–2022 · research · R01

Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever

Thomas William Geisbert · Texas A&M University at Galveston · funded by National Institutes of Health

$1.2MViral Infections and Vectors

2017–2021 · research · R01

Microbiota metabolites, GPR, and inflammatory bowel diseases

Yingzi Cong · Texas A&M University at Galveston · funded by National Institutes of Health

$348.8kGut microbiota and health

2017–2024 · research · R01

Hydrogen Sulfide and NRF2 Cross-talk in Viral Infections

Antonella Casola · Texas A&M University at Galveston · funded by National Institutes of Health

$503.8kSulfur Compounds in Biology

2017–2022 · research · R01

Pathogenic Role of EPAC1 Signaling in Retinopathy of Prematurity

Wenbo Zhang · Texas A&M University at Galveston · funded by National Institutes of Health

$387.5kRetinopathy of Prematurity Studies

2017–2021 · research · R01

Structure and function of DNA polymerase lambda opposite DNA lesions which disrupt Watson-Crick base pairing

Louise Prakash · Texas A&M University at Galveston · funded by National Institutes of Health

$262.7kDNA Repair Mechanisms

2017–2019 · grant · Standard Grant

RAPID Collaborative Research: Do mangroves provide better coastal protection than salt marshes? A Hurricane Harvey case study from Port Aransas, Texas, USA

Anna Armitage · Texas A&M University at Galveston · funded by National Science Foundation

$122.9k

2017–2024 · contract · N01

Task B13: Evaluation of MCMs directed against BSL-4 Viruses in Non-Human Primates (NHPs)

David Beasley · Texas A&M University at Galveston · funded by National Institutes of Health

$978.9k

2017–2024 · contract · N01

Task 2: Murine models of Ascending UTI Infection caused by Drug-Resistant Bacteria

David Beasley · Texas A&M University at Galveston · funded by National Institutes of Health

$627.7k

2017–2022 · cooperative agreement · U24

Academic Development of a Training Program for GLP in ABSL 3/4

Trevor Brasel · Texas A&M University at Galveston · funded by U.S. Food and Drug Administration

$60k

2017–2022 · research · R01

Role of Alcohol Metabolism in Alcoholic Chronic Pancreatitis

Bhupendra S Kaphalia · Texas A&M University at Galveston · funded by National Institutes of Health

$348.8kPancreatitis Pathology and Treatment

2017–2019 · fellowship · F31

Epigenetic Modulation of Amyloid Beta-resistant Synapses in Non-demented Subjects with Alzheimer's Neuropathology

Olga Zolochevska Cain · Texas A&M University at Galveston · funded by National Institutes of Health

$32.1k

2017–2018 · research · R01

Pathogenic Role of EPAC1 Signaling in Retinopathy of Prematurity

Wenbo Zhang · Texas A&M University at Galveston · funded by National Institutes of Health

$198.4kRetinopathy of Prematurity Studies

2017–2022 · research · R01

Pathogenic Role of EPAC1 Signaling in Retinopathy of Prematurity

Wenbo Zhang · Texas A&M University at Galveston · funded by National Institutes of Health

$372.7kRetinopathy of Prematurity Studies

2017–2024 · contract · N01

Task A29: Evaluation of Candidate Medical Countermeasures for Inhalational Anthrax in the NZW Rabbit Model

David Beasely · Texas A&M University at Galveston · funded by National Institutes of Health

$1.2M

2017–2024 · contract · N01

Task C11: Using a Human Lung Microphysiologic System to Model SARS-CoV-2 Infection and Test Candidate Countermeasures

David Beasley · Texas A&M University at Galveston · funded by National Institutes of Health

$228.5k

2017–2019 · grant · Standard Grant

NSF Rapid: Urgent sampling zooplankton for assessing ecosystem restoration of G alveston Bay after catastrophic impacts of Hurricane Harvey

Hui Liu · Texas A&M University at Galveston · funded by National Science Foundation

$100.1k

2017–2022 · research · R01

Role of Alcohol Metabolism in Alcoholic Chronic Pancreatitis

Bhupendra S Kaphalia · Texas A&M University at Galveston · funded by National Institutes of Health

$348.8kPancreatitis Pathology and Treatment

2017–2019 · fellowship · F31

Regulation of Cellular and Humoral Responses to Mouse Malaria

Victor Hugo Carpio Rojas · Texas A&M University at Galveston · funded by National Institutes of Health

$33.3kMalaria Research and Control

2017–2023 · research · R01

(PQ9) A NOVEL MECHANISM OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY AND POTENTIAL TREATMENT

Qing Yang · Texas A&M University at Galveston · funded by National Institutes of Health

$343.8k

2017 · contract · N01

Task B1: ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT

David Beasley · Texas A&M University at Galveston · funded by National Institutes of Health

$2 909

2017–2022 · research · R01

The Germinal Center and T cell help in Three Phases of Clearance of Plasmodium

Robin Stephens · Texas A&M University at Galveston · funded by National Institutes of Health

$393.6kMalaria Research and Control

2017–2024 · contract · N01

Task A39: In Vivo Efficacy in Rat Pulmonary Yersinia pestis Infection Model

Christy Bray · Texas A&M University at Galveston · funded by National Institutes of Health

$425k

2017–2024 · research · R01

Microbiota metabolites, GPR, and inflammatory bowel diseases

Yingzi Cong · Texas A&M University at Galveston · funded by National Institutes of Health

$348.8kGut microbiota and health